Table 3.
SK | A549 | |||||||
---|---|---|---|---|---|---|---|---|
High | Moderate | Low | (-) | High | Moderate | Low | (-) | |
Filters (N = 48) | 1 | 0 | 3 | 44 | 0 | 8 | 34 | 6 |
EDC (N = 35) | 0 | 1 | 5 | 29 | 1 | 6 | 10 | 18 |
EDCP (N = 38) | 0 | 2 | 14 | 22 | 3 | 2 | 11 | 22 |
Masks (N = 6) | 0 | 0 | 3 | 3 | 0 | 0 | 6 | 0 |
Gloves (N = 2) | 1 | 1 | 0 | 0 | 2 | 0 | 0 | 0 |
Coriolis (N = 48) | 0 | 0 | 0 | 48 | 0 | 0 | 1 | 47 |
Settled Dust (N = 13) | 6 | 7 | 0 | 0 | 6 | 7 | 0 | 0 |
8 (4.21%) | 11 (5.79%) | 25 (13.16%) | 146 (76.84%) | 12 (6.31%) | 23 (12.11%) | 62 (32.63%) | 93 (48.95%) |
A549, human alveolar epithelial cells; SK, human liver carcinoma cells; EDC, Electrostatic dust collector; High, IC50≥3rd dilution; Moderate, IC50 at 2nd dilution; Low, IC50 at 1st dilution; (-), no cytotoxicity.